Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 1;276(5):e645.
doi: 10.1097/SLA.0000000000005309. Epub 2021 Nov 18.

Comment on: The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-Negative Esophageal Adenocarcinoma

Sichao Wang  1 , Shujie Huang  1   2 , Zhen Gao  1 , Weitao Zhuang  3   2 , Rixin Chen  1   4 , Guibin Qiao  1
Affiliations
Comment

Comment on: The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-Negative Esophageal Adenocarcinoma

Sichao Wang et al. Ann Surg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Comment on

References

    1. Rucker AJ, Raman V, Jawitz OK, et al. The impact of adjuvant therapy on survival after esophagectomy for node-negative esophageal adenocarcinoma. Ann Surg. 2022;275:348–355.
    1. Wu H, Zhuang W, Huang S, et al. Optimal range of lymphadenectomy in pathological stage T1 and T2 esophageal squamous cell carcinoma. Front Oncol. 2021;11:619556.
    1. Prenzel KL, Bollschweiler E, Schröder W, et al. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg. 2010;90:1662–1667.
    1. Huang Q, Luo K, Chen C, et al. Identification and validation of lymphovascular invasion as a prognostic and staging factor in node-negative esophageal squamous cell carcinoma. J Thorac Oncol. 2016;11:583–592.

Supplementary concepts